Recent Quotes
/
Top Indices
Merck & Co., Inc. (NY: MRK)
47.33 USD  +0.62 (+1.33%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote Chart News SEC Filings
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 22,580,823
Open 46.46
Bid (Size) 47.45 (100)
Ask (Size) 47.48 (200)
Prev. Close 46.71
Today's Range 46.42 - 47.44
52wk Range 37.02 - 48.79
Shares Outstanding 3,019,611,844
Dividend Yield 3.59%
Top News
More News
UPDATE 2-Boy Scouts of America votes to end century-old ban on gay scouts
May 23, 2013
GRAPEVINE, Texas, May 23 (Reuters) - The Boy Scouts of America voted on Thursday to lift a century-old ban on openly gay scouts in a major victory for gay rights activists, but the decision means a sea... Read More
category companyNews
from Reuters: Company News
Merck halts development of experimental Parkinson's drug
May 23, 2013
May 23 (Reuters) - Merck & Co has ended development of preladenant, an experimental drug for Parkinson's disease, after initial data from three late-stage trials proved disappointing. Read More
category companyNews
from Reuters: Company News
Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue
May 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8367015 for the full story. Read More
from StreetInsider.com News Articles
Merck Issues Update on Phase III Trial for Preladenant
May 23, 2013
Merck (NYSE: MRK ), known as MSD outside the United States and Canada, today provided an update on the clinical program for preladenant, Merck's investigational adenosine A2[A ]receptor antagonist for... Read More
category Benzinga , News , MRK , and 1 more.
from Latest Articles from Benzinga.com

More News
Read More
Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine
May 23, 2013
from Business Wire News Releases
Corporate Stock Buybacks Driving Today's Action?
May 23, 2013
from StreetInsider.com News Articles
Inside Merck's new crusade against cervical cancer in Africa
May 23, 2013
category Health Care , Bill and Melinda Gates Foundation , U/S/ Food and Drug Administration , and 4 more.
from Business Journals
Save A Small Fortune By Forming Your Own Retirement Village
May 23, 2013
category NYSE:JNJ , NYSE:MRK , NYSE:ABT , and 2 more.
from Forbes Real Time
New Stock Coverage: Can Johnson & Johnson Be Market's Band-Aid?
May 23, 2013
category JNJ , MRK
from Minyanville Headlines
Why Dow Jones Laggards Are Important Leading Indicators
May 23, 2013
category Iron & Steel , Pharmaceuticals , IT Services & Computers , and 1 more.
from Trefis
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here